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Abstract Here we introduce the ‘‘Tet-Transgenic
Rodents’’ database, documenting most of the pub-
lished Tet-transgenic mouse lines generated in the past
2 decades. Aside from the[500 mouse lines listed, it
also includes the first of the recently reported Tet-
transgenic rat models. Since the Tet technology
comprises two essential components, a cis-acting
promoter (Ptet) and a trans-acting transactivator, the
database has been organized accordingly. One section
of the database summarizes the different transgenic
mouse lines carrying mostly tissue specific promoters
driving the Tet transactivator. Another section covers
transgenic mouse lines carrying responder transgenes
under Ptet control. The few existing rat transgenic lines
are listed correspondingly. It is the purpose of this
database to facilitate the repeated use of preexisting,
validated transgenic lines as a shortcut for further
research.
Keywords Tet system  Transactivator lines 
Responder lines  Database
Background
The development of transgenic mouse technologies
has made tremendous contributions to our in-depth
understanding of developmental and physiological
processes in mammalian organisms. Moreover, trans-
genic disease models provide valuable information on
pathophysiological processes, e.g. in cancer or in
neurological and metabolic disorders. The sophistica-
tion by which customized mouse models can be
generated has been aided in particular by two technol-
ogies based on functional elements derived from
prokaryotes: the Cre/loxP system and the Tet system
(Lewandoski 2001). They convey different forms of
conditionality to transgene expression. Generally
speaking, Cre/loxP allows for irreversible, stable
modification of the mouse genome via Cre recombi-
nase action. In contrast, the Tet system facilitates the
reversible modification of the transcriptome, due to the
action of tetracycline-controlled transcription factors.
The awareness of the scientific community to the
numerous Cre expressing and loxP site modified trans-
genic mouse lines was considerably raised through
databases maintained by researchers in this field
K. Scho¨nig
Central Institute of Mental Health, Medical Faculty
Mannheim / Heidelberg University, Mannheim, Germany
S. Freundlieb
TET Systems GmbH, Heidelberg, Germany
M. Gossen (&)
Berlin-Brandenburg Center for Regenerative Therapies
(BCRT), Fo¨hrer Str. 15, 13353 Berlin, Germany
e-mail: manfred.gossen@charite.de
M. Gossen
Max Delbru¨ck Center for Molecular Medicine,
Berlin, Germany
123
Transgenic Res
DOI 10.1007/s11248-012-9660-9
(Nagy et al. 2009; see also http://creline.org for a com-
pilation of the various databases available). In contrast,
the large number of transgenic mice generated with
components of the Tet regulatory system has so far not
been adequately compiled.
With this letter we want to convey a sense of the
multitude and diversity of such existing animals by
briefly introducing a database documenting the majority
of published Tet-transgenic mouse lines. We hope that
this freely available and continuously updated collec-
tion will foster the collaboration between researchers
intending to create new Tet-transgenic rodent models.
The Tet system
Over the past 2 decades tetracycline-controlled gene
expression established itself as the foremost principle
for small molecule-inducible gene expression in mam-
malian cells. Both the Tet-Off (Gossen and Bujard
1992) and Tet-On (Gossen et al. 1995) system also
found widespread application in transgenic mice. These
binary regulatory systems require (1) a transactivator
transgene, based on a fusion between the prokaryotic
Tet repressor (TetR) and a eukaryotic transactivation
domain and (2) a synthetic promoter (Ptet) designed to
be transcriptionally silent unless bound by the transac-
tivator. This is achieved by integration of TetR binding
sites (the tet operators, tetO) proximal to the core
promoter, rendering gene expression of the regulatory
system responsive to doxycycline. This tetracycline
derivative binds to the TetR moiety of the transactiva-
tors, thereby controlling their DNA binding either in a
positive (Tet-On) or negative (Tet-Off) way. In the vast
majority of applications of the Tet system in transgenic
mice, transactivator lines and responder lines (with the
gene of interest under Ptet control) have initially been
generated independently. Double transgenic mice are
then obtained by breeding. This strategy has several
advantages:
Fig. 1 Screenshot of the table for mouse lines expressing Tet
transregulator genes. Animals are ordered alphabetically
according to the promoter controlling transregulator expression.
The Pubmed links given refer to the original publication of the
transgenic line, not to subsequent ‘‘recycling’’ experiments. For
example, we are aware of 3 independently generated mouse
lines in which the albumin promoter drives expression of Tet
transregulators, with 2 lines utilizing a Tet-Off type and 1 line
utilizing a Tet-On type transactivator. The expected expression
pattern in cell types and/or organs are provided. Where
applicable, repositories distributing specific animals are indi-
cated, including an online link. Repositories covered are: The
Jackson Laboratories (http://jaxmice.jax.org/research/tet.html).
MMRRC (http://www.mmrrc.org/catalog/StrainCatalogSearch
Form.php?search_query=tTA%2C?rtTA%2C?tetO). EMMA
(http://www.emmanet.org/mutant_types.php?keyword=tet_exp
ression_system). RIKEN BRC (http://www.brc.riken.jp/lab/ani
mal/catalogue/Tetsystem.html)
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1. Expression units for the transactivator and respon-
der transgene do not interfere with each other’s
activity, as it has been observed for co-integrated
transgenes.
2. Both the responder and the activator line can be
characterized independently of each other (e.g.
using established reporter lines), with optimal
lines chosen for subsequent crosses and, most
importantly in the context of this letter,
3. Individual lines generated with a substantial effort
can be ‘‘re-used’’ for subsequent experiments. For
example, several ‘‘popular’’ transactivator mouse
lines like CCSP-rtTA (Tichelaar et al. 2000) or
Keratin14-rtTA (Nguyen et al. 2006) have been
re-used in numerous subsequent studies by other
laboratories to study questions in lung and skin
biology, respectively. Likewise, specific respon-
der lines e.g. coding for a tightly controlled
Diphtheria toxin (Lee et al. 1998) have been used
in a variety of scientific questions to ablate cells of
many different tissues and organs like cardiac
muscle, liver, pancreas, brain etc., depending on
the transactivator expression pattern. Thus similar
or analogous questions as in the original study
may be asked, and results can be directly
compared as the animals are isogenic for either
the transactivator or the responder transgene.
Alternatively, researchers often take advantage of
well characterized transgenic lines e.g. expressing
a transactivator in a defined organ or tissue, which
then can be bred to entirely different responder
transgenes, thus addressing a multitude of unre-
lated questions. For more examples for these
scenarios, see Scho¨nig et al. (2010).
The database
Maximizing the potential benefits of utilizing previously
established Tet-transgenic lines requires knowledge of
their existence. By collecting such information and also
by highlighting the availability of numerous of these Tet
mouse lines in transgenic mouse repositories we wish to
contribute to further dissemination of the technology and
to ease access to specific lines. Lastly, we also started to
collect information on Tet-transgenic rats, the number of
which presumably will increase rapidly within the next
years.
Figures 1, 2, and 3 show screenshots of exemplary
sections of the database as it will appear when accessed
online. The figure legends provide a short introduction
to the database including links to repositories distrib-
uting many of the transgenic animals. The database
itself can be found at http://www.tetsystems.com/file
admin/tettransgenicrodents.pdf.
Finally, we like to apologize to those colleagues
who published novel Tet-transgenic lines and whose
work escaped our attention. We like to encourage you
to contact us via info@tetsystems.com to have your
original transactivator or responder line incorporated
into the database.
Fig. 2 Screenshot of the table for mouse lines expressing tTA/rtTA responsive genes of interest. Animals are ordered alphabetically
according to the gene placed under control of Ptet. For information regarding the references and repositories, refer to Figure 1
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